LGT Group Foundation’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
LGT Group Foundation's GILD Position: Q2 2025 in Review
LGT Group Foundation sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 3,248 shares — an estimated $364K sold.
LGT Group Foundation first reported a position in GILD in Q4 2021 and held it in 14 quarters. The position peaked at $7.05M in Q3 2022. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.
- LGT Group Foundation reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
- LGT Group Foundation sold 3,248 Gilead Sciences shares in Q2 2025, an estimated $364K.
- LGT Group Foundation first reported a position in Gilead Sciences in Q4 2021 and held it in 14 quarters.
- LGT Group Foundation's Gilead Sciences position peaked at $7.05M in Q3 2022.
- 2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.
Based on LGT Group Foundation's 13F filing for Q2 2025, filed 22 Jul 2025.